chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19-2, COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; The pharmacist called on behalf of the doctor. Two doses of bivalent Moderna COVID19 vaccine given reporting day, but they expired last night at 9:30 PM.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The pharmacist called on behalf of the doctor. Two doses of bivalent Moderna COVID19 vaccine given reporting day, but they expired last night at 9:30 PM.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 01-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 01-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (The pharmacist called on behalf of the doctor. Two doses of bivalent Moderna COVID19 vaccine given reporting day, but they expired last night at 9:30 PM.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The pharmacist called on behalf of the doctor. Two doses of bivalent Moderna COVID19 vaccine given reporting day, but they expired last night at 9:30 PM.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (The pharmacist called on behalf of the doctor. Two doses of bivalent Moderna COVID19 vaccine given reporting day, but they expired last night at 9:30 PM.).    Dosage text was reported as unknown. It was unknown if the vial underwent any temperature excursion. No concomitant information was reported. No treatment information was provided.  This case contains information for the 2nd patient out of 2 adult patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-713763 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-713763:Master case
Sex: U
Vaccine: COVID19-2, COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vials should have been discarded on 11Feb2023. She confirmed 8 doses were given after 11Feb2023. Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (vial size was initially stored in the refrigerator on 12-Jan-2023 and vaccine was administered on 11-Feb-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.     No treatment medications were reported.  This case contains information for the 1st of 8 adult patients described by the reporter.
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient administered the Moderna Bivalent as the 1st primary dose) and NO ADVERSE EVENT (No adverse event) in a 29-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7171B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Jan-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (patient administered the Moderna Bivalent as the 1st primary dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (patient administered the Moderna Bivalent as the 1st primary dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (patient administered the Moderna Bivalent as the 1st primary dose).    Concomitant medications details were not reported by the reporter. Patient did not have any previous COVID-19 vaccines besides the bivalent.  Treatment details was not reported by the reporter.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: t; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received first primary series of Moderna Covid-29 vaccine as the bivalent booster instead of the monovalent vaccine.) and NO ADVERSE EVENT (No adverse event) in a 40-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.       It was stated that no other adverse events were reported. No concomitant information was reported. No treatment information was provided.
Age: 14.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series) and NO ADVERSE EVENT (No adverse event) in a 14-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Feb-2023,  after starting , the patient experienced WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (A patient was administered a Moderna bivalent booster dose on 24Feb2023, before she got the primary series).    No concomitant medication was reported.    A patient was administered a Moderna bivalent booster dose on 24-Feb-2023, before she got the primary series. No treatment information was reported.
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine (6yrs and older) that was left at room temp for less than 48 hours, but more than 24 hours and was also administered it after 12 hours post puncture to 2 adult female patients), PRODUCT STORAGE ERROR (Moderna Bivalent vaccine (6yrs and older) that was left at room temp for less than 48 hours, but more than 24 hours) and NO ADVERSE EVENT (no adverse event) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     No Medical History information was reported.
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a dose of the Moderna Bivalent Covid-19 vaccine 1 day after 30 day expiration date in the refrigerator), PRODUCT STORAGE ERROR (Patient received a dose of the Moderna Bivalent Covid-19 vaccine 1 day after 30 day expiration date in the refrigerator) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 044H22A) for COVID-19 prophylaxis.   No Medical History information was reported.     No concomitant medications were reported.  No treatment information was provided.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP states that 4 patients were administered an expired dose of the Moderna COVID-19 vaccine) and NO ADVERSE EVENT (patient in this report did not experience any side effects) in a 9-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Feb-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP states that 4 patients were administered an expired dose of the Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (patient in this report did not experience any side effects). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP states that 4 patients were administered an expired dose of the Moderna COVID-19 vaccine) and NO ADVERSE EVENT (patient in this report did not experience any side effects) outcome was unknown.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Biopsy, Blister, Insomnia, Loss of personal independence in daily activities, Urticaria
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Patient have blisters on neck and shoulders), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (situation is Interfering with patient's daily life), INSOMNIA (can not sleep at nights) and URTICARIA (Chronic Hives and Urticaria) in a 71-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 056A22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Prevnar 20 (Patient had a Prevnar20 on B14H00L but does not remember on what date). Past adverse reactions to the above products included No adverse event with Prevnar 20. Concurrent medical conditions included Multiple sclerosis (   ).   Reporter did not allow further contact
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature decreased, Decreased appetite, Expired product administered
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of BODY TEMPERATURE DECREASED (The patient in this report had reported a low grade temperature), DECREASED APPETITE (The patient in this report had reported a low grade temperature and poor appetite on 1MAR2023) and EXPIRED PRODUCT ADMINISTERED (HCP states that 4 patients were administered an expired dose of the Moderna COVID-19 vaccine on 27FEB2023.) in an 8-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    O  Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Mar-2023: Non significant live follow up received.
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE PAIN (Sore spot on his right arm of administration.) and FATIGUE (Little fatigued) in an elderly male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Type 2 diabetes mellitus and Hypertension. Concomitant products included INFLUENZA VACCINE for an unknown indication.    In September 2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore spot on his right arm of administration.) and FATIGUE (Little fatigued). At the time of the report, VACCINATION SITE PAIN (Sore spot on his right arm of administration.) and FATIGUE (Little fatigued) had resolved.
Sex: M
Vaccine: COVID19-2, COVID19
Symptoms: COVID-19, Fatigue, Pain in extremity
Clinical narrative: This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE PAIN (Sore spot on his right arm of administration.) and FATIGUE (Little fatigued) in an elderly male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Concurrent medical conditions included Type 2 diabetes mellitus and Hypertension. Concomitant products included INFLUENZA VACCINE for an unknown indication.    In September 2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore spot on his right arm of administration.) and FATIGUE (Little fatigued). At the time of the report, VACCINATION SITE PAIN (Sore spot on his right arm of administration.) and FATIGUE (Little fatigued) had resolved.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) in an 8-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 27-Feb-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine).    No concomitant medications were reported.  The patient in this report did not experience any side effects.  No treatment medications were reported.
Sex: F
Vaccine: COVID19-2
Symptoms: Feeling abnormal
Clinical narrative: really felt down and out; This spontaneous case was reported by a patient family member or friend and describes the occurrence of FEELING ABNORMAL (really felt down and out) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (really felt down and out). At the time of the report, FEELING ABNORMAL (really felt down and out) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Dosage text was reported as Unknown. The caller reported that she has one friend who received her Moderna Covid-19 vaccines and really felt down and out after receiving Moderna Covid-19 vaccines. No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was administered a dose after the published expiration date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date) and NO ADVERSE EVENT (No adverse event ) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date) and NO ADVERSE EVENT (No adverse event ). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date) and NO ADVERSE EVENT (No adverse event ) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event ) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose after the published expiration date).    Much information was not known. No concomitant medications were reported. No treatment medications were reported.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Balance disorder, Coordination abnormal, Hypoaesthesia, Neuropathy peripheral, Paraesthesia
Clinical narrative: With a month of being vaccinated I have full neoropathy systems. Numbness, tingling, kiss of balance. Loss of coordination, pins and needles. It has been going on for 2 years.
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthma, Condition aggravated, Lower respiratory tract infection, Nasopharyngitis, Respiratory tract congestion
Clinical narrative: On 10/20/2022, I got what I thought was a heavy cold. I thought it was also possible that I had contracted COVID-19. I tested myself a few times and was negative. The cold ended up migrating into my chest, causing chest congestion and triggering my asthma. I ended up needing refills on my inhalers. That has all stayed with me to present with no change. I ended up with sinus congestion with severe sinus headaches. I treated that with Tylenol sinus severe. I am also still experiencing postnasal drip. I have an appointment with an E.N.T. this month and an appointment with a pulmonologist in May.
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test negative, Sinus congestion, Sinus headache, Upper-airway cough syndrome
Clinical narrative: On 10/20/2022, I got what I thought was a heavy cold. I thought it was also possible that I had contracted COVID-19. I tested myself a few times and was negative. The cold ended up migrating into my chest, causing chest congestion and triggering my asthma. I ended up needing refills on my inhalers. That has all stayed with me to present with no change. I ended up with sinus congestion with severe sinus headaches. I treated that with Tylenol sinus severe. I am also still experiencing postnasal drip. I have an appointment with an E.N.T. this month and an appointment with a pulmonologist in May.
Age: 38.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Asthenopia, Blindness unilateral, Central nervous system lesion, Corrective lens user, Headache
Clinical narrative: I had my vaccination on 03/05/2022. On 05/26/2022 I had a headache that turned into a bad migraine. It started to affect my eyesight. Eye strain. It kept getting worse and were prescribed glasses. I lost my vision in my left eye. and then I went to the emergency room on 06/05/2022 as the pain was so bad. I had an MRI and Spinal Tap on 06/05/2022. I was diagnosed with Optic Neuritis in left eye and lesions throughout my brain. I was diagnosed with Multiple Sclerosis. I have ongoing medical appointments and I see the Neurologist 04/20/2023.
Age: 38.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Lumbar puncture, Magnetic resonance imaging abnormal, Migraine, Multiple sclerosis, Optic neuritis
Clinical narrative: I had my vaccination on 03/05/2022. On 05/26/2022 I had a headache that turned into a bad migraine. It started to affect my eyesight. Eye strain. It kept getting worse and were prescribed glasses. I lost my vision in my left eye. and then I went to the emergency room on 06/05/2022 as the pain was so bad. I had an MRI and Spinal Tap on 06/05/2022. I was diagnosed with Optic Neuritis in left eye and lesions throughout my brain. I was diagnosed with Multiple Sclerosis. I have ongoing medical appointments and I see the Neurologist 04/20/2023.
Age: 38.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Pain, Visual impairment
Clinical narrative: I had my vaccination on 03/05/2022. On 05/26/2022 I had a headache that turned into a bad migraine. It started to affect my eyesight. Eye strain. It kept getting worse and were prescribed glasses. I lost my vision in my left eye. and then I went to the emergency room on 06/05/2022 as the pain was so bad. I had an MRI and Spinal Tap on 06/05/2022. I was diagnosed with Optic Neuritis in left eye and lesions throughout my brain. I was diagnosed with Multiple Sclerosis. I have ongoing medical appointments and I see the Neurologist 04/20/2023.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Expired product administered
Clinical narrative: pt given expired vaccine
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Tender, red, and itchy at injection site. Mild headache and joint pain. Symptoms lasted 9-10 days.
Age: 77.0
Sex: F
Vaccine: FLUA4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received her yearly flu vaccination at one of our mobile vaccination clinics. We were unaware she had already received her 22-23 yearly flu vaccination from pharmacy until we tried to bill for the vaccination. Patient did not notify us she had already received a flu vaccination. No none adverse events at this time.
Age: 4.0
Sex: F
Vaccine: MMRV
Symptoms: Dry skin, Injection site reaction, Papule, Rash erythematous, Skin lesion
Clinical narrative: This was given at the same time and in the same arm as the KINRIX vaccine (lot number 5ay2j). Child dev red rash at site of both injections ( MMRV worse than Kinrix) then following day with red lesions and some with dryness but no vesicles on neck/ face and trunk. none on palms or soles but some papules on webs of fingers. no itching; no F/V/D
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, C-reactive protein normal, Chiropractic, Injected limb mobility decreased, Injection site pain
Clinical narrative: Since early to mid-December 2022, I have had sharp pains on the shoulders. I thought that maybe I had slept in the wrong position, because I'm a side sleeper. The left shoulder is more affected, but I also have pain in the right shoulder. The pain sometimes radiates from the shoulder to the elbow on both arms. On the left hand, it sometimes radiates from the wrist to the fingers. I can't lift my arms more than 35 degrees. I can't sleep at night, because the pain is so severe. Since 12/17/2022, I have been constantly taking ibuprofen and acetaminophen every six hours. On 12/19/2022, I went to the chiropractor. He gave me treatment consisting of manual adjustment of shoulder, neck, and back. He also gave me tens stimulation, ultrasound therapy, and spinal decompression therapy. Since then, I have been seeing my chiropractor regularly. I sometimes go twice in a week, and other times I've gone three times a week. In January 2023, the pain became more tolerable, so I stopped going to the chiropractor. However, I continued to take the ibuprofen and acetaminophen. On 1/26/2023, I woke up with severe pain in both shoulders. Instead of going to the chiropractor, I went to my PCP, who gave me a cortisone shot. I got a little bit better, and continued taking the ibuprofen and acetaminophen, though I took it less often than before. On or about 2/16/2023, I started having more severe pain. I couldn't see my PCP that day, because he was on vacation, so I ended up seeing the on-call physician at the clinic on 2/21/2023. He gave me two cortisone shots (one in each arm). It didn't help at all with the pain. On 2/24/2023, I started seeing my chiropractor again. At the time of this writing, I see him three times a week. The pain is still severe and intense (especially at night). I can't sleep well at night because of the pain. On 3/2/2023, I saw my PCP. My PCP did a CRP blood test and an ESR blood test. The results of the tests fell within the normal range. At the time of this writing, I am taking acetaminophen and ibuprofen every four hours. My PCP has referred me to a neurologist to undergo an EMG test, which is scheduled for the near future.
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Mobility decreased, Pain, Pain in extremity, Red blood cell sedimentation rate normal, Sleep disorder
Clinical narrative: Since early to mid-December 2022, I have had sharp pains on the shoulders. I thought that maybe I had slept in the wrong position, because I'm a side sleeper. The left shoulder is more affected, but I also have pain in the right shoulder. The pain sometimes radiates from the shoulder to the elbow on both arms. On the left hand, it sometimes radiates from the wrist to the fingers. I can't lift my arms more than 35 degrees. I can't sleep at night, because the pain is so severe. Since 12/17/2022, I have been constantly taking ibuprofen and acetaminophen every six hours. On 12/19/2022, I went to the chiropractor. He gave me treatment consisting of manual adjustment of shoulder, neck, and back. He also gave me tens stimulation, ultrasound therapy, and spinal decompression therapy. Since then, I have been seeing my chiropractor regularly. I sometimes go twice in a week, and other times I've gone three times a week. In January 2023, the pain became more tolerable, so I stopped going to the chiropractor. However, I continued to take the ibuprofen and acetaminophen. On 1/26/2023, I woke up with severe pain in both shoulders. Instead of going to the chiropractor, I went to my PCP, who gave me a cortisone shot. I got a little bit better, and continued taking the ibuprofen and acetaminophen, though I took it less often than before. On or about 2/16/2023, I started having more severe pain. I couldn't see my PCP that day, because he was on vacation, so I ended up seeing the on-call physician at the clinic on 2/21/2023. He gave me two cortisone shots (one in each arm). It didn't help at all with the pain. On 2/24/2023, I started seeing my chiropractor again. At the time of this writing, I see him three times a week. The pain is still severe and intense (especially at night). I can't sleep well at night because of the pain. On 3/2/2023, I saw my PCP. My PCP did a CRP blood test and an ESR blood test. The results of the tests fell within the normal range. At the time of this writing, I am taking acetaminophen and ibuprofen every four hours. My PCP has referred me to a neurologist to undergo an EMG test, which is scheduled for the near future.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Diarrhoea, Haematochezia, Mucous stools, Occult blood negative
Clinical narrative: Patient developed diarrhea over the 24 hours after receiving vaccines. Over the next 2 days, she had mucous loose stools and one episode of blood-streaked stools. No periods of inconsolability, vomiting, fevers. Feeding well. When she was seen 3 days after the vaccine, she was still having looser, mucous stools but had not had any further bloody stools.
Age: 69.0
Sex: F
Vaccine: PNC20
Symptoms: Back pain, Breast pain, Chest pain, Erythema, Swelling
Clinical narrative: LEFT BREAST HURTS, CHEST HURTS, BACK PAIN, SWELLING, PINKNESS
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness
Clinical narrative: Patient received this vaccination along with boostrix and Havrix and came back to pharmacy approximately 30 minutes post-administration stating that she felt dizzy, but also stated she hadnt eaten since breakfast and it was after 5:00pm so she felt the dizziness could be related to that
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Pyrexia, Respiratory tract congestion
Clinical narrative: I had fatigue, sore throat, mild congestion, low-grade, and fever. I tested positive for COVID-19. I spoke to my doctor and they prescribed Paxlovid. I tested negative in 5 days.  When I got back from work I felt bad again and tested positive again for COVID-19. I had the same symptoms but milder.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had fatigue, sore throat, mild congestion, low-grade, and fever. I tested positive for COVID-19. I spoke to my doctor and they prescribed Paxlovid. I tested negative in 5 days.  When I got back from work I felt bad again and tested positive again for COVID-19. I had the same symptoms but milder.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: I got COVID - 19 a few months following my vaccination. I got a prescription of Paxlovid but I didn't take it because my case wasn't that severe. My physician explained the side effects and recommend I hold off on taking it.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Develped shingles on right arm and chest lasted for a month, in December had flare up of PMR prescribed prednisone.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: complaining of pain in upper left arm, pt spoke to doctor and will go to pain specialist (pt suffers from chronic pain syndrome). pt got vaccine in 7/22 but has reported pain to pharmacy on 3/6/23. Time course unknown but may have been for a couple of months now.
Age: 51.0
Sex: M
Vaccine: HPV9
Symptoms: Wrong product administered
Clinical narrative: Patient was intended to receive Prevnar and received HPV vaccine instead.
Age: 41.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Biopsy breast abnormal, Breast cancer female, Breast conserving surgery, Gene mutation identification test negative, Invasive ductal breast carcinoma
Clinical narrative: I was having 6-month mammograms to keep an eye on a spot I found in 2021. When I went for my mammogram on January 6, 2023, the doctor found a new spot within the last 6 months. The spot was biopsied January 18th, 2023, and the next day it was confirmed that it was Invasive Ductal Carcinoma. I had genetic testing done and all the tests were negative so it's not because of a genetic mutation. I had a Lumpectomy surgery on February 23, 2023, and I will be having radiation and chemotherapy starting this month. Surgery confirmed that I am stage 1A.
Age: 41.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Magnetic resonance imaging breast abnormal, Mammogram abnormal
Clinical narrative: I was having 6-month mammograms to keep an eye on a spot I found in 2021. When I went for my mammogram on January 6, 2023, the doctor found a new spot within the last 6 months. The spot was biopsied January 18th, 2023, and the next day it was confirmed that it was Invasive Ductal Carcinoma. I had genetic testing done and all the tests were negative so it's not because of a genetic mutation. I had a Lumpectomy surgery on February 23, 2023, and I will be having radiation and chemotherapy starting this month. Surgery confirmed that I am stage 1A.
Age: 3.0
Sex: F
Vaccine: HIBV
Symptoms: Device connection issue, Underdose
Clinical narrative: MA inserted vaccine needle in pt left thigh. needle entered thigh and when plugger was pushed to administer vaccine syringe detached from needle all medication spilling out. MA could verify any medication was administered.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: Pt. was given an expired Kinrix vaccine EXP 03/03/2023, child was doing fine. Mother was notified of incident and follow up appointment given.
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Behaviour disorder, COVID-19, Chest X-ray normal, Computerised tomogram head normal
Clinical narrative: Patient is a 77 y.o. male patient of MD with history of cataract, dementia, ambulatory dysfunction, hyperlipidemia presented to Doctors Hospital with fall. Problem based management in the hospital is as follows:   Sepsis w Covid-19 Virus Infection w hypoxia, POA, now resolved Generalized weakness w mechanical fall  Acute metabolic encephalopathy, resolved Late onset alzheimer dementia w behavioral disturbance Presented w generalized weakness, mechanical fall and encephalopathy Likely 2/2 worsening dementia with COVID-19 infection   Date of covid positive test: 01/28/23 Vaccination status: vaccinated Imaging: Chest x-ray with no acute process Was initially hypoxic, 87% on room air, requiring 2 L.  Now more than 90% on room air Medical therapy: Was given dexamethasone, remdesivir and tocilizumab per ID recs ID following Anticipated special isolation end date: 02/7/23   Acute metabolic encephalopathy, improved Late onset alzheimer dementia w behavioral disturbance Acute decompensation due to COVID CT head and C-spine did not show any acute process Continued memantine, Trazadone and zoloft Admitted under delirium precautions PT/OT/utilization management consulted   Hyperlipidemia Continued statins   After 4 days of hospital stay, patient was doing well so he was discharged in stable condition
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram spine, Dementia Alzheimer's type, Fall, Hyperlipidaemia, Hypoxia
Clinical narrative: Patient is a 77 y.o. male patient of MD with history of cataract, dementia, ambulatory dysfunction, hyperlipidemia presented to Doctors Hospital with fall. Problem based management in the hospital is as follows:   Sepsis w Covid-19 Virus Infection w hypoxia, POA, now resolved Generalized weakness w mechanical fall  Acute metabolic encephalopathy, resolved Late onset alzheimer dementia w behavioral disturbance Presented w generalized weakness, mechanical fall and encephalopathy Likely 2/2 worsening dementia with COVID-19 infection   Date of covid positive test: 01/28/23 Vaccination status: vaccinated Imaging: Chest x-ray with no acute process Was initially hypoxic, 87% on room air, requiring 2 L.  Now more than 90% on room air Medical therapy: Was given dexamethasone, remdesivir and tocilizumab per ID recs ID following Anticipated special isolation end date: 02/7/23   Acute metabolic encephalopathy, improved Late onset alzheimer dementia w behavioral disturbance Acute decompensation due to COVID CT head and C-spine did not show any acute process Continued memantine, Trazadone and zoloft Admitted under delirium precautions PT/OT/utilization management consulted   Hyperlipidemia Continued statins   After 4 days of hospital stay, patient was doing well so he was discharged in stable condition
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Metabolic encephalopathy, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient is a 77 y.o. male patient of MD with history of cataract, dementia, ambulatory dysfunction, hyperlipidemia presented to Doctors Hospital with fall. Problem based management in the hospital is as follows:   Sepsis w Covid-19 Virus Infection w hypoxia, POA, now resolved Generalized weakness w mechanical fall  Acute metabolic encephalopathy, resolved Late onset alzheimer dementia w behavioral disturbance Presented w generalized weakness, mechanical fall and encephalopathy Likely 2/2 worsening dementia with COVID-19 infection   Date of covid positive test: 01/28/23 Vaccination status: vaccinated Imaging: Chest x-ray with no acute process Was initially hypoxic, 87% on room air, requiring 2 L.  Now more than 90% on room air Medical therapy: Was given dexamethasone, remdesivir and tocilizumab per ID recs ID following Anticipated special isolation end date: 02/7/23   Acute metabolic encephalopathy, improved Late onset alzheimer dementia w behavioral disturbance Acute decompensation due to COVID CT head and C-spine did not show any acute process Continued memantine, Trazadone and zoloft Admitted under delirium precautions PT/OT/utilization management consulted   Hyperlipidemia Continued statins   After 4 days of hospital stay, patient was doing well so he was discharged in stable condition
Age: 37.0
Sex: M
Vaccine: COVID19-2, FLUR4
Symptoms: Anaphylactic shock, Blood test, Cardiac arrest, Choking, Coma
Clinical narrative: anaphylactic shock, causing choking on food, causing cardiac arrest, given three doses of epinephrine by paramedics, taken to hospital emergency and remains in a coma since 12/01/2022.
Age: 37.0
Sex: M
Vaccine: COVID19-2, FLUR4
Symptoms: Laboratory test, Magnetic resonance imaging, X-ray
Clinical narrative: anaphylactic shock, causing choking on food, causing cardiac arrest, given three doses of epinephrine by paramedics, taken to hospital emergency and remains in a coma since 12/01/2022.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, Blood lactic acid, C-reactive protein abnormal
Clinical narrative: A 74 y.o. female patient of MD with history of Tremor, neuropathy, T2DM, Hx of breast Ca,  presented to  Hospital with Cough, SOB, Fever   Sepsis COVID19 pneumonia Acute hypoxic respiratory failure 2 days duration of feeling sick, persistent cough productive of greenish/ streaked  blood sputum and SOB Fever, high temp of 100.9, leukocytosis of 12, lactic acid of 3.3, tachycardia, CXR non acute, 02 sat 88, requiring 2 lit NC 02 Immunized x3 will hold further IV abx for now Continue steroids and remdesivir IS/PEP, Mucinex, continues pulse ox Lactate now WNL CRP now improving Weaned to room air and discharged with prescription to complete course of decadron   AKI on CKD stage 3 Cr 1.5 Has received IV fluids in ER Tolerating PO Creatinine improved Monitor U/O and renal parameters   T2DM with hyperglycemia Last A1c 6.5   Hyperlipidemia Continue home atorvastatin   Diabetic polyneuropathy Trigeminal neuralgia Resume carbamazepine and gabapentin   Depression/Anxiety Continue home buspar and remeron
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray normal, Chronic kidney disease, Cough, Dyspnoea
Clinical narrative: A 74 y.o. female patient of MD with history of Tremor, neuropathy, T2DM, Hx of breast Ca,  presented to  Hospital with Cough, SOB, Fever   Sepsis COVID19 pneumonia Acute hypoxic respiratory failure 2 days duration of feeling sick, persistent cough productive of greenish/ streaked  blood sputum and SOB Fever, high temp of 100.9, leukocytosis of 12, lactic acid of 3.3, tachycardia, CXR non acute, 02 sat 88, requiring 2 lit NC 02 Immunized x3 will hold further IV abx for now Continue steroids and remdesivir IS/PEP, Mucinex, continues pulse ox Lactate now WNL CRP now improving Weaned to room air and discharged with prescription to complete course of decadron   AKI on CKD stage 3 Cr 1.5 Has received IV fluids in ER Tolerating PO Creatinine improved Monitor U/O and renal parameters   T2DM with hyperglycemia Last A1c 6.5   Hyperlipidemia Continue home atorvastatin   Diabetic polyneuropathy Trigeminal neuralgia Resume carbamazepine and gabapentin   Depression/Anxiety Continue home buspar and remeron
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin normal, Haemoptysis, Leukocytosis, Malaise, Productive cough
Clinical narrative: A 74 y.o. female patient of MD with history of Tremor, neuropathy, T2DM, Hx of breast Ca,  presented to  Hospital with Cough, SOB, Fever   Sepsis COVID19 pneumonia Acute hypoxic respiratory failure 2 days duration of feeling sick, persistent cough productive of greenish/ streaked  blood sputum and SOB Fever, high temp of 100.9, leukocytosis of 12, lactic acid of 3.3, tachycardia, CXR non acute, 02 sat 88, requiring 2 lit NC 02 Immunized x3 will hold further IV abx for now Continue steroids and remdesivir IS/PEP, Mucinex, continues pulse ox Lactate now WNL CRP now improving Weaned to room air and discharged with prescription to complete course of decadron   AKI on CKD stage 3 Cr 1.5 Has received IV fluids in ER Tolerating PO Creatinine improved Monitor U/O and renal parameters   T2DM with hyperglycemia Last A1c 6.5   Hyperlipidemia Continue home atorvastatin   Diabetic polyneuropathy Trigeminal neuralgia Resume carbamazepine and gabapentin   Depression/Anxiety Continue home buspar and remeron
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Sepsis, Sputum discoloured, Tachycardia, White blood cell count increased
Clinical narrative: A 74 y.o. female patient of MD with history of Tremor, neuropathy, T2DM, Hx of breast Ca,  presented to  Hospital with Cough, SOB, Fever   Sepsis COVID19 pneumonia Acute hypoxic respiratory failure 2 days duration of feeling sick, persistent cough productive of greenish/ streaked  blood sputum and SOB Fever, high temp of 100.9, leukocytosis of 12, lactic acid of 3.3, tachycardia, CXR non acute, 02 sat 88, requiring 2 lit NC 02 Immunized x3 will hold further IV abx for now Continue steroids and remdesivir IS/PEP, Mucinex, continues pulse ox Lactate now WNL CRP now improving Weaned to room air and discharged with prescription to complete course of decadron   AKI on CKD stage 3 Cr 1.5 Has received IV fluids in ER Tolerating PO Creatinine improved Monitor U/O and renal parameters   T2DM with hyperglycemia Last A1c 6.5   Hyperlipidemia Continue home atorvastatin   Diabetic polyneuropathy Trigeminal neuralgia Resume carbamazepine and gabapentin   Depression/Anxiety Continue home buspar and remeron
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Asthma, Blood culture negative, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is a 69 y.o. female patient of MD.   Report on admission: Patient is a 69 y.o. female presenting from home with c/o 69-year-old female with a history of COPD presents emergency department with shortness of breath for 1 week.  Shortness of breath definitely worsened despite taking her inhaler at home.  Patient was admitted in November for same and was in the ICU on BiPAP.  Patient also reports COVID-positive end of December Husband at bedside reports at the trach location there is airway stenosis which is inoperable.   Hospital course as below.  Cardiology and pulmonology followed patient during stay.  Patient improved with medical treatment.  Patient discharged to SNF in stable condition.  Patient will need close monitoring of vital signs.   1.  COVID PNA: -pulm followed -COVID +12/26, positive again on 1/7/2023 -CT chest with very low lung volumes, bilateral groundglass infiltrates reflecting pulmonary edema versus pneumonia -isolation completed 1/18/23  2.  Asthma: -pulm consulted  3.  Acute hypoxic respiratory failure: -Likely in setting of above -Wean oxygen as able  4.  Sepsis trigger: -1/7 blood cultures no growth to date  5.  Type 2 diabetes, hyperglycemia/hypoglycemia: -In setting of steroids -A1c 7.5 -Sliding scale insulin, adjust home meds  6.  UTI: -Urine culture positive for enterococcus faecalis -abx completed   7. Tachycardia: -cardio consulted
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram thorax abnormal, Culture urine positive, Dyspnoea, Enterococcus test positive, Glycosylated haemoglobin increased
Clinical narrative: Patient is a 69 y.o. female patient of MD.   Report on admission: Patient is a 69 y.o. female presenting from home with c/o 69-year-old female with a history of COPD presents emergency department with shortness of breath for 1 week.  Shortness of breath definitely worsened despite taking her inhaler at home.  Patient was admitted in November for same and was in the ICU on BiPAP.  Patient also reports COVID-positive end of December Husband at bedside reports at the trach location there is airway stenosis which is inoperable.   Hospital course as below.  Cardiology and pulmonology followed patient during stay.  Patient improved with medical treatment.  Patient discharged to SNF in stable condition.  Patient will need close monitoring of vital signs.   1.  COVID PNA: -pulm followed -COVID +12/26, positive again on 1/7/2023 -CT chest with very low lung volumes, bilateral groundglass infiltrates reflecting pulmonary edema versus pneumonia -isolation completed 1/18/23  2.  Asthma: -pulm consulted  3.  Acute hypoxic respiratory failure: -Likely in setting of above -Wean oxygen as able  4.  Sepsis trigger: -1/7 blood cultures no growth to date  5.  Type 2 diabetes, hyperglycemia/hypoglycemia: -In setting of steroids -A1c 7.5 -Sliding scale insulin, adjust home meds  6.  UTI: -Urine culture positive for enterococcus faecalis -abx completed   7. Tachycardia: -cardio consulted
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperglycaemia, Hypoglycaemia, Intensive care, Lung infiltration, Lung opacity
Clinical narrative: Patient is a 69 y.o. female patient of MD.   Report on admission: Patient is a 69 y.o. female presenting from home with c/o 69-year-old female with a history of COPD presents emergency department with shortness of breath for 1 week.  Shortness of breath definitely worsened despite taking her inhaler at home.  Patient was admitted in November for same and was in the ICU on BiPAP.  Patient also reports COVID-positive end of December Husband at bedside reports at the trach location there is airway stenosis which is inoperable.   Hospital course as below.  Cardiology and pulmonology followed patient during stay.  Patient improved with medical treatment.  Patient discharged to SNF in stable condition.  Patient will need close monitoring of vital signs.   1.  COVID PNA: -pulm followed -COVID +12/26, positive again on 1/7/2023 -CT chest with very low lung volumes, bilateral groundglass infiltrates reflecting pulmonary edema versus pneumonia -isolation completed 1/18/23  2.  Asthma: -pulm consulted  3.  Acute hypoxic respiratory failure: -Likely in setting of above -Wean oxygen as able  4.  Sepsis trigger: -1/7 blood cultures no growth to date  5.  Type 2 diabetes, hyperglycemia/hypoglycemia: -In setting of steroids -A1c 7.5 -Sliding scale insulin, adjust home meds  6.  UTI: -Urine culture positive for enterococcus faecalis -abx completed   7. Tachycardia: -cardio consulted